Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00274326 · ClinicalTrials.gov registry record · Phase 3
DILIPO (DILutIonal HyPOnatremia)
A Phase 3 study of Congestive Heart Failure, sponsored by Sanofi.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
- 15
- Study locations
NCT00274326: Completed Phase 3 study of Congestive Heart Failure, sponsored by Sanofi.
NCT00274326 is a Phase 3 study of Congestive Heart Failure that has completed, run by Sanofi. The registered enrollment target is 150 participants, below the 327-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (54% lower). The trial reports 15 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00274326, a Phase 3 study of Congestive Heart Failure, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
- 15
- Study locations
Study Summary
Primary: * To assess the efficacy of SR121463B in correcting hyponatremia in patients with dilutional hyponatremia other than SIADH or cirrhosis Secondary: * To assess the long-term efficacy of SR121463B in maintaining normonatremia in these patients * To assess the safety and tolerability of SR121463B
Conditions Studied
Interventions
- DRUG SR121463B
Study Locations (15)
Other
- Sanofi-Aventis Administrative Office - Buenos Aires
- Sanofi-Aventis Administrative Office - Diegem
- Sanofi-Aventis Administrative Office - Laval
- Sanofi-Aventis Administrative Office - Santiago
- Sanofi-Aventis Administrative Office - Hørsholm
- Sanofi-Aventis Administrative Office - Athens
- Sanofi-Aventis Administrative Office - Budapest
- Sanofi-Aventis Administrative Office - Netanya
- Sanofi-Aventis Administrative Office - Warsaw
- Sanofi-Aventis Administrative Office - Porto Salvo
- Sanofi-Aventis Administrative Office - Bucharest
- Sanofi-Aventis Administrative Office - Midrand
- Sanofi-Aventis Administrative Office - Bromma
New Jersey
- Sanofi-Aventis Administrative Office - Bridgewater
New South Wales
- sanofi-aventis Australia & New Zealand administrative office - Macquarie Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-07 |
| Phase | Phase 3 |
What the finished NCT00274326 record still lists
NCT00274326 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 327-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which SR121463B is the first listed.
NCT00274326 lists 15 locations in 3 states (Other, New Jersey, New South Wales).
Frequently Asked Questions
What is clinical trial NCT00274326 about?
NCT00274326 is a clinical study titled "DILIPO (DILutIonal HyPOnatremia)". Primary: * To assess the efficacy of SR121463B in correcting hyponatremia in patients with dilutional hyponatremia other than SIADH or cirrhosis Secondary: * To assess the long-term efficacy of SR121463B in maintaining normonatremia in these patients * To assess the safety and tolerability of SR1...
What is the current status of trial NCT00274326?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2005-05. Estimated completion is 2007-07.
What conditions does trial NCT00274326 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT00274326?
The interventions under investigation include: SR121463B (DRUG).
Who is sponsoring clinical trial NCT00274326?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00274326 being conducted?
This trial has 15 study locations across New Jersey, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00274326's enrollment target sits among peer trials
150 24th of 51 higher than 27 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
COMPLETED · Phase 3
-
Study to Evaluate the Safety of Twice Daily Oral Carvedilol
COMPLETED · Phase 3
-
Palliative Care for People With HF
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia